35 results
8-K
EX-10.2
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
and costs of defense and investigation), amounts paid in settlement or expenses, joint or several, (collectively, “Claims”) incurred in investigating … , preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court
8-K
EX-3.1
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
and by appropriate proceedings, taxes for which they maintain adequate reserves therefor in accordance with GAAP.
(p) Independent Investigation. At the request of any … shall deliver written notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
) against loss with respect thereto.
(t) Litigation. There is no material action, suit, arbitration, proceeding, inquiry or investigation before … or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director or officer
8-K
EX-10.3
o4kfcv7c3spp8bgh
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
kd0838paoyqy 5veslz
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
60iglnjbexcecn3
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-10.1
5pg8 3c5j2t
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B5
clazmj27bk
23 Dec 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
q0a9vq0mhf69pom8
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
0t45eobux 4lztcebg
1 Dec 21
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
6av4slx0cnkxb6twtad
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
j61v5
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
5ontqiyaih
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
sow6k26p7p1btla6
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
te12gk5vi9lxfizxmfz8
31 Mar 21
Annual report
4:30pm